Looking to balance out your exposure to GRAL? The ETFs below have historically moved differently from GRAL, which may reduce portfolio volatility when combined in a suitable allocation. The stock ideas table highlights individual companies with the same low-correlation characteristics. Correlation can change and does not guarantee that one asset will rise when another falls.
Best Diversifiers for GRAL
1 ETFs have low correlation with GRAL (below 0.3), 0 of which are negatively correlated.
How candidates are selected| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Category | Compare |
|---|---|---|---|---|---|---|---|
| VanEck Oil Services ETF | 0.09 | — | — | 74 | Energy Equities | GRAL vs OIH | |
| United States Copper Index Fund | 0.32 | — | — | 68 | Copper, Metals | GRAL vs CPER | |
| Global X US Infrastructure Development ETF | 0.40 | — | — | 55 | Infrastructure Equities, Industrials Equities | GRAL vs PAVE | |
| iShares Copper and Metals Mining ETF | 0.41 | — | — | 75 | Copper | GRAL vs ICOP | |
| Wedbush LAFFER|TENGLER New Era Value ETF | 0.43 | — | — | 79 | Dividend, Large Cap Value Equities | GRAL vs TGLR |
To view more results, upgrade your current subscription plan.
Low-Correlation Stock Ideas
The table shows companies with at least $1B in market capitalization, historical correlation data for GRAL, and a Risk / Return Rank of 50 or higher. Treat them as research candidates rather than evidence that they will offset a future decline. The least correlated is Exxon Mobil Corporation (XOM) (Energy) with a 1Y correlation of -0.28, down from -0.08 over 5 years.
How candidates are selected| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Sector |
|---|---|---|---|---|---|---|
| Exxon Mobil Corporation | -0.28 | -0.08 | -0.08 | 84 | Energy | |
| Chevron Corporation | -0.23 | — | — | 72 | Energy | |
| Occidental Petroleum Corporation | -0.20 | -0.01 | -0.01 | 65 | Energy | |
| Johnson & Johnson | 0.02 | 0.05 | 0.05 | 96 | Healthcare | |
| Royalty Pharma plc | 0.13 | — | — | 95 | Healthcare |
To view more results, upgrade your current subscription plan.
Build a portfolio that complements GRAL
Add GRAL to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.
Analyze a portfolio with GRAL